Literature DB >> 1193724

Arthritis of mice induced by Mycoplasma pulmonis: humoral antibody and lymphocyte responses of CBA mice.

B C Cole, L Golightly-Rowland, J R Ward.   

Abstract

Peak arthritis occurred 14 days after intravenous injection of Mycoplasma pulmonis and persisted in some mice at low levels for 84 days. A marked lymphocytosis occurred during the first week of infection with only a slight increase in polymorphonuclear leukocytes. Complement-fixing antibodies appeared in low titer 3 days after infection and moderate levels persisted for 84 days. The metabolic-inhibiting and mycoplasmacidal antibody responses were absent or minimal. M. pulmonis appeared to be mitogenic for mouse lymphocytes as evidenced by (i) increased uptake of [3H]thymidine for normal lymphocytes exposed to various concentrations of nonviable M. pulmonis antigen, and (ii) a 13-fold increase in [3H]thymidine uptake in lymphocytes taken from mice 3 days after infection with M. pulmonis in the absence of added antigen. Lymphocytes taken from infected mice transformed significantly more at all time periods than control lymphocytes when exposed to M. pulmonis antigen. This response was maximal at 3 days and minimal at 21 to 35 days after infection. Lymphocytes sensitized to M. pulmonis did not transform when exposed to M. arthritidis antigen or vice versa. M. pulmonis infection had no effect upon the mitogenic responses of lymphocytes to phytohemagglutinin or lipopolysaccharide. There was no statistically significant correlation between persistence of arthritis and degree of humor antibody or lymphocyte responses. However, persisting arthritis was associated with a higher incidence of mycoplasma isolations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1193724      PMCID: PMC415401          DOI: 10.1128/iai.12.5.1083-1092.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

2.  EXPERIMENTAL PROLIFERATIVE ARTHRITIS IN MICE PRODUCED BY FILTRABLE, PLEUROPNEUMONIA-LIKE MICROORGANISMS.

Authors:  A B Sabin
Journal:  Science       Date:  1939-03-10       Impact factor: 47.728

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Patterns of cytomegaloviral complement-fixing antibody activity: a longitudinal study of blood donors.

Authors:  J L Waner; T H Weller; S V Kevy
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

5.  Extensive transformation of lymphocytes by a mycoplasma organism.

Authors:  H Ginsburg; J Nicolet
Journal:  Nat New Biol       Date:  1973-12-05

6.  Blast-like transformation induced in peripheral blood lymphocytes by cellular injury: a comparison of sonication and phytohemagglutinin.

Authors:  A Turk; P R Glade; L N Chessin
Journal:  Blood       Date:  1969-02       Impact factor: 22.113

7.  Tissue cultures and mycoplasmas.

Authors:  L Hayflick
Journal:  Tex Rep Biol Med       Date:  1965-06

8.  The serological identity of Sabin's murine type C mycoplasma and Mycoplasma pulmonis.

Authors:  R M Lemcke; K A Forshaw; R J Fallon
Journal:  J Gen Microbiol       Date:  1969-09

9.  Chronic proliferative arthritis of mice induced by Mycoplasma arthritidis: demonstration of a cell-mediated immune response to mycoplasma antigens in vitro.

Authors:  B C Cole; L Golightly-Rowland; J R Ward
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

10.  Immunological response of rodents to murine mycoplasmas.

Authors:  B C Cole; L Golightly-Rowland; J R Ward; B B Wiley
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

View more
  19 in total

Review 1.  Immunity to mycoplasma infections of the respiratory tract: a review.

Authors:  G Taylor
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 5.344

2.  New models of chronic synovitis in rabbits induced by mycoplasmas: microbiological, histopathological, and immunological observations on rabbits injected with Mycoplasma arthritidis and Mycoplasma pulmonis.

Authors:  B C Cole; M M Griffiths; E J Eichwald; J R Ward
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

4.  Effects of lymecycline on Mycoplasma pulmonis-induced arthritis in mice.

Authors:  G Taylor; D Taylor-Robinson; E C Keystone
Journal:  Br J Exp Pathol       Date:  1978-04

5.  Monoclonal antibodies that inhibit mitogenic activity of Mycoplasma pulmonis.

Authors:  Z Lapidot; R Siman-Tov; Y Naot
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Characterization of the metabolism inhibition antigen of Mycoplasma arthritidis.

Authors:  L R Washburn; J R Ramsay; L K Roberts
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

7.  Mycoplasma pulmonis infection of the murine oropharynx protects against subsequent vaginal colonization.

Authors:  P M Furr; D Taylor-Robinson
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

8.  Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes.

Authors:  Y Naot; S Merchav; E Ben-David; H Ginsburg
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

9.  Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis.

Authors:  B Evengård; K Sandstedt; G Bölske; R Feinstein; I Riesenfelt-Orn; C I Smith
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

10.  Induction of interferon in ovine and human lymphocyte cultures by mycoplasmas.

Authors:  B C Cole; J C Overall; P S Lombardi; L A Glasgow
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.